 |
The Journal of Neuroscience, April 26, 2006, 26(17):4690-4700; doi:10.1523/JNEUROSCI.0792-06.2006
Previous Article | Next Article 
Cellular/Molecular
Dopamine D1 Activation Potentiates Striatal NMDA Receptors by Tyrosine Phosphorylation-Dependent Subunit Trafficking
Penelope J. Hallett,
Robert Spoelgen,
Bradley T. Hyman,
David G. Standaert, and
Anthone W. Dunah
MassGeneral Institute for Neurodegenerative Disease, Harvard Medical School and Massachusetts General Hospital, Charlestown, Massachusetts 02129
Correspondence should be addressed to Dr. Anthone W. Dunah, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, 114 16th Street, B114-2125, Charlestown, MA 02129. Email: dunah{at}helix.mgh.harvard.edu
Interactions between dopaminergic and glutamatergic afferents in the striatum are essential for motor learning and the regulation of movement. An important mechanism for these interactions is the ability of dopamine, through D1 receptors, to potentiate NMDA glutamate receptor function. Here we show that, in striatal neurons, D1 receptor activation leads to rapid trafficking of NMDA receptor subunits, with increased NR1 and NR2B subunits in dendrites, enhanced coclustering of these subunits with the postsynaptic density scaffolding molecule postsynaptic density-95, and increased surface expression. The dopamine D1 receptor-mediated NMDA receptor trafficking is blocked by an inhibitor of tyrosine kinases. Blockers of tyrosine phosphatases also induce NMDA subunit trafficking, but this effect is nonselective and alters both NR2A- and NR2B-containing receptors. Furthermore, tyrosine phosphatase inhibition leads to the clustering of tyrosine-phosphorylated NR2B subunit along dendritic shafts. Our findings reveal that D1 receptor activation can potentiate striatal NMDA subunit function by directly promoting the surface insertion of the receptor complexes. This effect is regulated by the reciprocal actions of protein tyrosine phosphatases and tyrosine kinases. Modification of these pathways may be a useful therapeutic target for Parkinsons disease and other basal ganglia disorders in which abnormal function of striatal NMDA receptors contributes to the symptoms of the diseases.
Key words: glutamate receptors; NMDA receptors; dopamine receptors; striatal neurons; tyrosine phosphorylation; receptor trafficking
Received Dec. 9, 2005;
revised March 24, 2006;
accepted March 27, 2006.
Correspondence should be addressed to Dr. Anthone W. Dunah, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, 114 16th Street, B114-2125, Charlestown, MA 02129. Email: dunah{at}helix.mgh.harvard.edu
This article has been cited by other articles:

|
 |

|
 |
 
J. Xu, P. Kurup, Y. Zhang, S. M. Goebel-Goody, P. H. Wu, A. H. Hawasli, M. L. Baum, J. A. Bibb, and P. J. Lombroso
Extrasynaptic NMDA Receptors Couple Preferentially to Excitotoxicity via Calpain-Mediated Cleavage of STEP
J. Neurosci.,
July 22, 2009;
29(29):
9330 - 9343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Varela, S. J. Hirsch, D. Chapman, L. S. Leverich, and R. W. Greene
D1/D5 Modulation of Synaptic NMDA Receptor Currents
J. Neurosci.,
March 11, 2009;
29(10):
3109 - 3119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pisani and J. Shen
Levodopa-induced dyskinesia and striatal signaling pathways
PNAS,
March 3, 2009;
106(9):
2973 - 2974.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Tong and A. J. Gibb
Dopamine D1 receptor inhibition of NMDA receptor currents mediated by tyrosine kinase-dependent receptor trafficking in neonatal rat striatum
J. Physiol.,
October 1, 2008;
586(19):
4693 - 4707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Sun, M. Milovanovic, Y. Zhao, and M. E. Wolf
Acute and Chronic Dopamine Receptor Stimulation Modulates AMPA Receptor Trafficking in Nucleus Accumbens Neurons Cocultured with Prefrontal Cortex Neurons
J. Neurosci.,
April 16, 2008;
28(16):
4216 - 4230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zhang, L. Edelmann, J. Liu, J. E. Crandall, and M. A. Morabito
Cdk5 Regulates the Phosphorylation of Tyrosine 1472 NR2B and the Surface Expression of NMDA Receptors
J. Neurosci.,
January 9, 2008;
28(2):
415 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jurd, C. Thornton, J. Wang, K. Luong, K. Phamluong, V. Kharazia, S. L. Gibb, and D. Ron
Mind Bomb-2 Is an E3 Ligase That Ubiquitinates the N-Methyl-D-aspartate Receptor NR2B Subunit in a Phosphorylation-dependent Manner
J. Biol. Chem.,
January 4, 2008;
283(1):
301 - 310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Moyer, J. A. Wolf, and L. H. Finkel
Effects of Dopaminergic Modulation on the Integrative Properties of the Ventral Striatal Medium Spiny Neuron
J Neurophysiol,
December 1, 2007;
98(6):
3731 - 3748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. V. Venkitaramani, J. Chin, W. J. Netzer, G. K. Gouras, S. Lesne, R. Malinow, and P. J. Lombroso
{beta}-Amyloid Modulation of Synaptic Transmission and Plasticity
J. Neurosci.,
October 31, 2007;
27(44):
11832 - 11837.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Liu, E. Y. Yuen, P. B. Allen, J. Feng, P. Greengard, and Z. Yan
Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin
PNAS,
November 28, 2006;
103(48):
18338 - 18343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Schilstrom, R. Yaka, E. Argilli, N. Suvarna, J. Schumann, B. T. Chen, M. Carman, V. Singh, W. S. Mailliard, D. Ron, et al.
Cocaine Enhances NMDA Receptor-Mediated Currents in Ventral Tegmental Area Cells via Dopamine D5 Receptor-Dependent Redistribution of NMDA Receptors.
J. Neurosci.,
August 15, 2006;
26(33):
8549 - 8558.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|